CleanCore Solutions, Inc. ZONE

Healthcare SIC 2842 - Specialty Cleaning, Polishing and Sanitation Preparations NYSE

of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. We have a patented nanobubble technology

using aqueous ozone that we believe is highly effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas.

safe, clean spaces that are free from any chemical residue or skin irritants. We are currently expanding our distributor network, improving

our production processes, and proving the effectiveness of our products in restaurants, airports, and hotels.

Last close 0.15 2026-09-04
Market cap $34.3M 2026-03-31 share count
52-week range 0.12 - 5.36

Valuation FY2025 figures against the last close

P/S16.5x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022
Revenue $2.1M$1.6M
Cost of revenue $1.1M$809.2K
Gross profit $986.5K$795.8K
SG&A $7.1M$2.5M
Operating income -$6.4M-$1.9M
Interest expense $356.1K$335.0K
Net income -$6.7M-$2.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022
Cash and equivalents $1.5M$2.0M$393.2K
Receivables $657.7K$467.3K$233.6K
Inventory $1.3M$672.3K$672.1K
Total current assets $3.8M$3.2M$1.7M
Property, plant and equipment $32.5K$10.6K$1.2K
Goodwill $2.2M$2.2M$2.2M$2.2M
Other intangibles $2.0M$1.5M$1.6M
Total assets $8.5M$7.5M$6.1M
Accounts payable $909.3K$176.1K$266.5K
Total current liabilities $2.8M$1.5M$3.9M
Total liabilities $7.0M$3.7M$4.3M
Retained earnings -$14.0M-$7.3M-$5.0M
Total equity $1.5M$3.7M$1.7M-$6.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022
Operating cash flow -$2.3M-$1.5M
Depreciation and amortisation $203.8K$155.1K$63
Stock-based compensation $3.2M$671.0K
Capital expenditure $32.4K$10.4K
Investing cash flow -$614.2K-$10.4K
Financing cash flow $2.4M$3.2M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-25-079975.

Others in SIC 2842

TickerCompanyMarket capP/ERevenue growth
CLX CLOROX CO /DE/ $11.25B 14.3x 0.2%